Thu, 03 Jul 2025 | ADMINISTRATION
AMLo Biosciences, a life sciences firm based in Newcastle, has fallen into administration and ceased trading after failing to secure the investment required to continue operations.
The company was founded in 2017 and was spun out from Newcastle University. It specialised in prognostic tests for early-stage skin cancers, typically melanomas, and was based in The Biosphere at Helix.
According to administrators, the company had sought to secure new investment, but this “was not forthcoming in the required timeline.” As a result, Grant Thornton and Tax LLP were engaged to undertake an accelerated sale of the business.
The administrators said that, despite “tangible interest”, a deal could not be concluded quickly enough. “Consequently,” they said, “the directors resolved that it would be in the best interests of the company and its creditors for the directors to place the company into administration.”
Chris Petts and James Hitchens of Grant Thornton were subsequently appointed as joint administrators on June 25, 2025. Upon their appointment, the company immediately ceased trading, with all 11 staff made redundant. However, administrators have said that discussions with interested parties remain ongoing.
The joint administrators added that they “are currently focused on exploring a sale of the company’s assets, including significant intellectual property, and assisting former employees in submitting claims to the Redundancy Payments Service.”
AMLo Biosciences operated in both the UK and US and had previously raised more than £4 million in funding from the North East Innovation Fund - managed by Northstar Ventures - Ascension, Conduit, Innovate UK, Esperante Ventures, Future Planet Capital and several angel investors.
In the company’s accounts for the year to November 30 2024, its fixed assets were valued at around £563,000 and current assets at over £850,000. At the time, however, its net liabilities exceeded £620,000.
Find out more about M&A in the MedTech sector, as well as the funding challenges that many smaller businesses face
When acquiring intellectual property assets, buyers should be aware of a number of crucial considerations.
This highly profitable independent dispensing pharmacy in Birmingham boasts a prime suburban location, filling approximately 10,000 prescriptions monthly.
LEASEHOLD
This well-established domiciliary care business in Cambridgeshire has demonstrated strong year-on-year revenue growth since its inception in 2018.
This well-established social care company, situated in Yorkshire, boasts eight owned supported living properties and has secured contracts with local authorities, ensuring a steady stream of revenue.
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.